Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Neoplasms 3Smoking Cessation 1Smoking 1Neurocognitive Disorders 1Multiple Endocrine Neoplasia Type 1 1Motor Activity 1Leukemia 1Hematologic Neoplasms 1Graft vs Host Disease 1Depression 1Cognitive Dysfunction 1Chronic Disease 1

Interventions

Cyclophosphamide 5Radiotherapy 4Cyclosporine 4Antilymphocyte Serum 4Busulfan 3fludarabine phosphate 2Therapeutics 2Mycophenolic Acid 2Methylprednisolone 2Filgrastim 2Cord Blood Stem Cell Transplantation 2thymoglobulin 1sargramostim 1Whole-Body Irradiation 1Voriconazole 1Thalidomide 1Polymerase Chain Reaction 1Physical Therapy Modalities 1Peripheral Blood Stem Cell Transplantation 1Methotrexate 1Melphalan 1Interferon alpha-2 1Immunoenzyme Techniques 1Health 1Fluconazole 1Flow Cytometry 1Fibroblast Growth Factor 7 1Etoposide 1Dexamethasone 1Bronchoscopy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Graft vs Host Disease × Health × Clear all
NCT02976558 2019-12-18

TriCAM

University of Erlangen-Nürnberg Medical School

Phase NA Terminated
104 enrolled
Other hematologic neoplasm

Depression, Graft vs Host Disease, Leukemia, Hematologic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡